Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.

Slični predmeti

• A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
  od: Turner, H, i dr.
  Izdano: (1999)
• Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
  od: Turner, H, i dr.
  Izdano: (2004)
• Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?
  od: Ramírez, C, i dr.
  Izdano: (2012)
• Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
  od: Karavitaki, N, i dr.
  Izdano: (2008)
• A single-center open-label study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide Autogel in patients with acromegaly previously treated with octreotide.
  od: Kelly, P, i dr.
  Izdano: (2010)